Published Date: 13 Mar 2023
Some adults do not consider the importance of testing, while others believe that a healthy diet with regular bowel movements does not require testing, according to the study.
Read Full NewsMind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Sneha Mantri, MD, MS. [LISTEN TIME: 24 minutes]
Inebilizumab is the first CD19-targeted B-cell therapy approved for antiAChR- or antiMuSK antibody–positive generalized myasthenia gravis, providing symptom control with twice-yearly dosing.
Weight-Adjusted Waist Index Can Predict CVD Risk in Cardiovascular Kidney Metabolic Syndrome
1.
Research finds low uptake of supportive care at the end-of-life for patients with advanced cancer
2.
mRNA-based COVID vaccines generate improved responses to immunotherapy
3.
FDA Approves Hemophilia B Second Gene Therapy.
4.
The risk of ovarian cancer is not increased by salpingectomy, according to JAMA.
5.
'Ray of hope': New developments in the fight against various cancers.
1.
Oncology Partnerships: Driving Innovation Through Strategic Collaborations and Pharma Engagement USA
2.
Unveiling the Secrets of Early Cancer: Emerging Strategies to Decipher Its Biology
3.
Unpacking Chordoma: Understanding the Rare Cancer and its Treatment Options
4.
AI-Driven Chemotherapy: Transforming Cancer Care with Precision and Efficiency
5.
Unveiling Canine Blood Clots Over Time: A Look at Low-Field MRI's Diagnostic Potential
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
3.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
4.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation